2007
DOI: 10.3748/wjg.v13.i5.717
|View full text |Cite
|
Sign up to set email alerts
|

Experimental study of therapeutic efficacy of Baicalin in rats with severe acute pancreatitis

Abstract: AIM:To observe the therapeutic efficacy of Baicalin in rats with severe acute pancreatitis (SAP) and explore its therapeutic mechanisms. METHODS:The SAP rat models were randomly divided into the model control group, Baicalin treatment group, octreotide treatment group and sham operation group. All groups were randomly subdivided into 3 h, 6 h and 12 h groups with 15 rats in each group. The survival, ascites volume and pathological changes of pancreas in all rats were observed at different time points after ope… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
47
0

Year Published

2007
2007
2014
2014

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 33 publications
(47 citation statements)
references
References 30 publications
0
47
0
Order By: Relevance
“…Ten minutes after successful modeling, Baicalintreated group was first injected 5% Baicalin injection (10 mg/100 g) via the external jugular vein, followed by continuous intravenous administration (10 mg/h per 100 g) by microinfusion pump. Octreotide-treated group was first injected octreotide (0.2 μg/100 g) via the external jugular vein, followed by continuous intravenous transfusion (10 mg/h per 100 g) by microinfusion pump at a transfusion speed of 0.2 μg/h per 100 g. All abovementioned dosages have been proved as effective dosages in the previous preliminary experiment [10] . Both the sham operation group and model control group were injected normal saline of equivalent volume at the corresponding time points after operation.…”
Section: Dosagementioning
confidence: 96%
See 2 more Smart Citations
“…Ten minutes after successful modeling, Baicalintreated group was first injected 5% Baicalin injection (10 mg/100 g) via the external jugular vein, followed by continuous intravenous administration (10 mg/h per 100 g) by microinfusion pump. Octreotide-treated group was first injected octreotide (0.2 μg/100 g) via the external jugular vein, followed by continuous intravenous transfusion (10 mg/h per 100 g) by microinfusion pump at a transfusion speed of 0.2 μg/h per 100 g. All abovementioned dosages have been proved as effective dosages in the previous preliminary experiment [10] . Both the sham operation group and model control group were injected normal saline of equivalent volume at the corresponding time points after operation.…”
Section: Dosagementioning
confidence: 96%
“…The improved Aho's method [10] was adopted to prepare 135 SAP rat models via retrograde injection of 35 g/L sodium taurocholate to the pancreatic duct through epidural catheter and duodenal papilla. The 135 SAP rat models were randomly assigned to the model group, Baicalintreated group and octreotide-treated group, 45 rats in each group, while other 45 rats were assigned to the sham operation group (SO group).…”
Section: Preparation Of Animal Modelsmentioning
confidence: 99%
See 1 more Smart Citation
“…Once complicated by multiple organ injury, the mortality rate of SAP is greatly increased [23,24]. When SAP develops, because the release of a variety of inflammatory mediators runs out of control, a cascade-like reaction is triggered.…”
Section: Discussionmentioning
confidence: 99%
“…The rats were given food and water ad libitum and fasted overnight before experiments. Rat SAP models were prepared by the method of Zhang et al (2007). The SAP rats were slowly injected 2 ml/kg body weight through the tail vein of either SPIO-liposomes (P group), SPIO-clodronateliposomes (T group), or saline (C group).…”
Section: Animal Models and Experimental Groupingmentioning
confidence: 99%